Skip to content
Screener

Moderna MRNA Other Non-Current Assets

Other Non-Current Assets at other companies

Novavax logo
NovavaxNVAX
$13.96M-34.7%
ALN
Alnylam PharmaceuticalsALNY
$65.13M+13.9%
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
$63M+4.8%
Roivant Sciences logo
Roivant SciencesROIV
$29.59M-4.9%
Vaxcyte, Inc. logo
Vaxcyte, Inc.PCVX
$155.54M+104%
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
$1.11M+120%

Other financials

Income statement

See full
Revenue$145.0M+2.1%
Gross profit$52.0M+126%
Operating income-$815.0M+10.1%
Net income-$782.0M+5.2%
EPS (diluted)-$1.97+7.5%

Balance sheet

See full
Cash & equivalents$1.7B+34.5%
Total debt$1.2B+60.8%
Total equity$6.8B-28.1%
Total assets$11.0B-8.7%

Cash flow

See full
Operating cash flow-$526.0M+42.8%
CapEx$37.0M+1,133%
Free cash flow-$563.0M+38.9%

Valuation

See full
Market cap$21.5B+107%
Enterprise value$21.01B+113%
P/S9.7×+6.3×

Profitability

See full
Gross margin23.4%-29.1pp
Operating margin-149%+99.9pp
Net margin-141.4%+141pp
FCF margin-132.4%

Returns & leverage

See full
Return on equity-39%+28.0pp
Debt / equity0.2×+0.1×
Current ratio2.3×-1.6×

Where this comes from

Reported directly by Moderna in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsMiscellaneousNoncurrent.

The source filing: Moderna’s 8-K, filed July 31, 2026. Open the filing →

Filed
Jul 31, 2026, 7:03 AM EDT
Accession
0001682852-26-000147

FAQ

What is Moderna's other non-current assets?
Moderna (MRNA) reported other non-current assets of $618M in Q2 2026.
How has Moderna's other non-current assets changed year-over-year?
Moderna's other non-current assets increased by 2709.1% year-over-year, from $22M to $618M.
What is the long-term trend for Moderna's other non-current assets?
Over 5 years (2020 to 2025), Moderna's other non-current assets has grown at a 91.9% compound annual growth rate (CAGR), from $2M to $52M.
What does other non-current assets mean?
Long-term assets not classified in specific categories — a catch-all for miscellaneous non-current assets.

Ask your AI about Moderna's other non-current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude